Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, March 2000, p. 245-250, Vol. 7, No. 2
Department of Microbiology and Immunology,
Texas Tech University Health Sciences Center, Lubbock, Texas
79430,1 and Department of Biological
Sciences, Texas Tech University, Lubbock, Texas
794092
Received 13 May 1999/Returned for modification 19 July
1999/Accepted 10 December 1999
Cocaine has been demonstrated to have a number of different effects
on immune cell functions. We have reported alterations of cellular
functions by macrophages (M Cocaine has been reported to exhibit
a variety of immunomodulatory effects on different immune functions
(30). Previous reports by us and others have demonstrated
that macrophages (M The chronic use of illicit drugs has been linked to an increased
susceptibility to viral infections (3, 5). In a series of
studies by Peterson et al., cocaine was reported to increase the
production of p24 antigen in human immunodeficiency virus (HIV)-infected, activated peripheral blood mononuclear cells (PBMC) (18-20). This increase was taken to indicate an increase in
HIV replication. Other researchers reported that cocaine increased p24
production in unstimulated PBMC but not in chronically infected mononuclear cell lines (1). Palamara et al. have described an increase in Sendai virus replication in epithelial cells cultured with cocaine in vitro, possibly caused by decreasing intracellular glutathione levels and increasing the redox state of the cells (15). Recently, our lab has described an antiviral activity of cocaine on murine peritoneal M The principal nonspecific mechanism used by cells to inhibit virus
replication is the stimulation of type I interferon (IFN) secretion.
The two type I IFNs shown to have potent antiviral activity are IFN- Experimental animals.
Male 6- to 8-week-old C57BL/6 mice
were purchased from Jackson Laboratories, Bar Harbor, Maine. All mice
were housed in the Laboratory Animal Research Center at Texas Tech
University Health Sciences Center and were cared for as stated in the
policies and regulations of the Institutional Animal Care and Use Committee.
Culture media and reagents.
Dulbecco's modified Eagle's
medium (DMEM) (Gibco, Long Island, N.Y.) was supplemented with 2%
fetal bovine serum (Intergen, Purchase, N.Y.), 25 mM HEPES (Fisher
Scientific, Pittsburgh, Pa.), and 50 mg of gentamicin sulfate (Fisher
Scientific) per liter. This medium is referred to as DMEM-S.
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cocaine Causes Increased Type I Interferon
Secretion by both L929 Cells and Murine Macrophages

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) exposed to cocaine in vitro, including
the inhibition of mouse hepatitis virus replication. Here, we present
evidence that cocaine stimulates the secretion of an antiviral product
that is neutralized by anti-interferon (anti-IFN). A dose-dependent
increase in the secretion of IFN by both M
and L929 cells incubated
with cocaine, with a concomitant decrease in virus replication, is also
reported. The increase in IFN secretion was most pronounced when cells
were cultured in the presence of the IFN inducer poly(I·C). The
effect of cocaine on IFN production was found to be primarily at the
transcript level in both M
and L929 cells. These findings further
support our previous research demonstrating an antiviral activity of
cocaine in vitro. The relevance of this activity to viral infections in general remains to be determined.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) exposed to cocaine in vitro displayed increased
phagocytosis of microorganisms (10), with an increased
production of reactive oxygen intermediates (28, 29) as well
as decreased cytokine secretion (24) and production of
reactive nitrogen intermediates (27). Further studies have
reported that cocaine enhanced neutrophil phagocytosis, increased
natural killer (NK) cell activity and distribution (26),
reduced the T-cell mitogen response (13), and reduced the
cytotoxic ability of splenic immune cells (14). Taken
together, these studies indicate that the effects of cocaine vary
considerably depending on which parameter of the immune repertoire is
investigated as well as the tools used to measure them.
infected with mouse hepatitis virus (MHV) in vitro (9). However, the mechanism(s) involved in this activity was not previously characterized.
and IFN-
(IFN-
/
). These cytokines have been demonstrated to
have myriad effects on cell functions, including development of an
antiviral state, inhibition of cell proliferation, and enhancement of
NK cell activity (22). IFN-
/
are secreted by most
nucleated cells in response to viral infection and affect virus
replication by inducing an antiviral state in an autocrine and
paracrine fashion (see reference 2;2 for review). In
this study, we have further characterized the effect of cocaine on virus replication in vitro. Using both primary M
cultures and the
L929 cell line, cocaine's effects on IFN-
/
secretion and virus
replication were investigated. These studies demonstrate that
cocaine's antiviral effect is mediated through an increase in IFN
secretion and that it regulates the production of IFN at least in part
at the mRNA level.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
/
(55,000 U/ml), anti-IFN-
(10,000 U/ml), and nonimmune control rabbit serum were obtained from
Access Biomedical, San Diego, Calif. Polyclonal anti-tumor necrosis
factor alpha (anti-TNF-
) was a gift from George Gifford, Dept. of
Microbiology at the University of Florida, Gainesville. Poly(I·C) and
DEAE-dextran were purchased from Sigma Chemical Co., St. Louis, Mo.
Cocaine hydrochloride was obtained from the National Institute of Drug
Abuse. Cocaine was dissolved in DMEM-S and filtered through a 0.22-µ
m-pore-size filter prior to use. No cytotoxicity to cocaine was noted
at any concentration employed in this study, as indicated by trypan
blue exclusion. All media and reagents were tested for
lipopolysaccharide (LPS) using the Limulus amoebocyte lysate
assay (Associates of Cape Cod, Cape Cod, Mass.) and were found to
contain less than 0.1 ng of LPS per ml.
M
collection and preparation.
To generate inflammatory
peritoneal M
, mice were injected intraperitoneally with 1 ml of 3%
thioglycolate broth (Baltimore Biological Laboratories, Baltimore,
Md.). M
were collected 4 days later and cultured as described
previously (9). Briefly, a peritoneal lavage was performed
using phosphate-buffered saline at pH 7.2, cells were sedimented at
250 × g, and then cells were resuspended in DMEM-S at
1.5 × 106/ml. One hundred microliters of cell
suspension was added to each well of a Costar (Cambridge, Mass.)
96-well tissue culture plate and allowed to adhere. Nonadherent cells
were removed and cultures were treated as described below.
Cell culture. L929 cells were a gift from Sam Baron (Galveston, Tex.) and were cultured in DMEM-S in Corning T-75 tissue culture flasks. Cells were removed using 0.25% trypsin supplemented with EDTA (Mediatech, Herndon, Va.) and plated on Costar 96-well tissue culture plates at a concentration of 1.2 × 105 to 1.5 × 105 cells/ml. After adherence, cells were incubated with various doses of cocaine from 6 to 48 h.
Viral plaque assay.
MHV strain MHV-JHM (ATCC VR-765) was
obtained from the American Type Culture Collection (Rockville, Md.).
The Indiana strain of vesicular stomatitis virus (VSV) was a gift from
Sam Baron. The viral plaque assay has been described previously
(9). Briefly, after M
or L929 cells were incubated with
cocaine, the culture media were discarded and 50 µl of virus (MHV or
VSV, respectively) diluted to approximately 40 PFU in DMEM-S was added.
The cells were then incubated for 1 h at 37°C before 100 µl of
overlay consisting of methylcellulose in DMEM-S was added. The plate
was incubated until plaque formation occurred, and the monolayers were
stained and fixed with 1% crystal violet (Sigma) in 80% methanol. The resulting viral plaques were counted, and a change in the number between control and treated wells was taken to indicate differences in
overall virus replication.
Transfer of antiviral activity. To determine if there was a release and accumulation of antiviral products into the culture media of cells incubated with cocaine, L929 cells were grown to confluence on 96-well plates and incubated with 0 or 100 µg of cocaine per ml for 24 h. The culture media were then removed, the cells were washed to remove residual cocaine, and fresh media without cocaine were added for 6, 12, 24, or 48 h. At the times indicated below, the culture media were collected, samples were pooled, and 100 µl/well was transferred to fresh L929 cells for 24 h. After this incubation, the media were removed and a viral plaque assay with VSV was performed as described above.
To determine the identity of the antiviral product in the transferred supernatants from the above-described experiments, 2 ml of each sample was incubated with 100 µl of anti-IFN-
/
(2,500 U/ml) or
nonimmune rabbit serum for 30 min before 100 µl/well was added to
fresh L929 cells. A viral plaque assay was performed 24 h later.
Direct effects of antisera.
When the effects of IFN were
determined directly on cocaine-exposed cells, the culture media were
discarded after a 24-h incubation and 20 µl of anti-IFN (2,750 U of
IFN-
/
per ml or 1,000 U of IFN-
per ml) in DMEM-S was added.
Those cells not receiving antisera were given 20 µl of control rabbit
serum. After a 30-min incubation, a viral plaque assay was performed as
described above except that the media in the wells were not discarded
before virus was added.
IFN bioassay.
L929 cells or M
were incubated with cocaine
for 24 or 48 h, respectively. The culture media were then
discarded and wells were washed to remove residual cocaine. One hundred
microliters of a synthetic double-stranded RNA molecule, poly(I·C),
at 1 or 3 µg/ml (M
and L929 cells, respectively) in DMEM was added
for 1 h. L929 cells also received 200 µg of DEAE-dextran per ml
to facilitate poly(I·C) incorporation. The cells were then washed twice to remove residual poly(I·C) and 100 µl of fresh media per ml
was added for 6 h. The culture media were pooled and stored at
70°C until assayed. To assess the IFN activity in the samples, fresh plates of L929 cells were cultured to confluence and twofold serial dilutions of samples were added for 18 h. A viral plaque assay with VSV was then performed as described earlier. The units of
IFN were determined by taking the reciprocal of the dilution that
inhibited the formation of 50% of the viral plaques.
RNase protection assay.
L929 cells or M
were cultured in
six-well plates with DMEM-S and cocaine for 24 or 48 h,
respectively. Media were then removed and 1 or 3 µg of poly(I·C)
per ml in DMEM was added, and cells were then incubated for 3 h.
Cells were lysed using TriZol (Gibco), and total cell RNA was collected
by phenol-chloroform extraction and ethanol precipitation. An RNase
protection assay was then performed on equal amounts of total cell RNA
from each treatment group using the RiboQuant multiprobe RNase
protection assay kit (PharMingen, San Diego, Calif.) per the
manufacturer's instructions. Briefly, 32P-labeled
antisense RNA probes (specific for the genes for TNF-
, interleukin-1
[IL-1
], MIP-1
, IFN-
, IFN-
4, IL-6, and
IFN-
and the genes for L32 and glyceraldehyde-3-phosphate
dehydrogenase [GAPDH], which are housekeeping genes) were hybridized
to sample RNA, an RNase specific for single-stranded RNA was added to
digest nonhybridized RNA, and the final products were resolved on an 8 M urea-polyacrylamide gel. The bands on the gel were then visualized by
autoradiography. To determine differences between treatments, the
amount of mRNA loaded in the lanes was normalized based on GAPDH or L32
band intensities using densitometry.
Statistical analysis of data. All of the above-described experiments were repeated at least twice in order to ensure reproducibility. A Student t test was used to determine the significance between two treatments. A one-way analysis of variance and Tukey posttest were used to determine significance between multiple groups. All values are reported as means ± standard errors of the means. Differences were considered significant at a P value of <0.05. In general, significance between control and experimental values is reported unless otherwise noted.
| |
RESULTS |
|---|
|
|
|---|
Effect of cocaine on virus replication in L929 cells.
When
L929 cells were incubated with 0 to 100 µg of cocaine per ml, they
exhibited increasing antiviral states as indicated by a dose-dependent
reduction in plaque formation by VSV (Fig. 1). The maximum effect was observed at
100 µg/ml (approximately 300 µM), which was the highest
concentration employed. A significant increase was noted when cells
were incubated with as little as 3 µg/ml. To determine if cocaine's
effect was limited to VSV, L929 cells were incubated with 0 to 100 µg
of cocaine per ml for 24 h and then a plaque assay was performed
using MHV. The dose-dependent reduction of MHV plaque formation by
cocaine was similar to the reduction seen with VSV (Fig. 1). L929 cells
did not display a time-dependent difference in virus replication (data
not shown) as noted previously with M
(9); however, a
significant reduction in plaque number was noted after 6 h of
incubation with cocaine. This was 18 h earlier than was observed
for M
.
|
Transfer of antiviral activity.
Direct exposure to cocaine has
been shown to induce antiviral activity in both M
and L929 cells.
Experiments were designed to determine if there was an accumulation of
antiviral activity in the culture media of L929 cells incubated with
cocaine. After incubation with 100 µg of cocaine per ml for 24 h, the cells were washed and fresh media without cocaine were added for
6, 12, 24, or 48 h. These cells displayed an antiviral effect for
as long as 48 h after removal of cocaine, indicating that cocaine
does not need to be present continuously (data not shown). When the culture media from the above-mentioned cells were transferred to fresh
L929 cells, the samples displayed antiviral activity that was not
evident until approximately 12 h after the removal of cocaine
(Fig. 2). The maximal effect was observed
at 24 h and began to diminish by 48 h.
|
/
per ml before
being placed on the fresh L929 cells, the antiviral activity was
abolished, in contrast to that in samples incubated with nonimmune rabbit serum (Fig. 3).
|
Anti-IFN-
/
reverses cocaine's effect.
Because the
previous experiments had shown that the addition of anti-IFN-
/
to
transferred culture media from cocaine-treated cells blocked antiviral
activity, experiments were performed to determine if this effect could
be produced on cells directly exposed to cocaine. L929 cells were
incubated with 0 or 100 µg of cocaine per ml for 24 h before
media were removed and 2,750 U of polyclonal anti-IFN-
/
per ml
(in 20 µl) was added for 30 min. Control cells received 20 µl of
nonimmune rabbit serum. A plaque assay was then performed. The addition
of anti-IFN-
/
reversed cocaine's antiviral activity (Fig.
4). However, anti-IFN-
produced only a
modest reversal and anti-TNF-
had no effect (data not shown).
|
Effects of cocaine on poly(I·C)-induced IFN and TNF-
secretion
in both L929 cells and M
.
Because the antiviral activity of
culture media from cocaine-treated cells was ablated by the presence of
anti-IFN-
/
, experiments were conducted to quantify the increase
in IFN secretion induced by cocaine. Both M
and L929 cells were
incubated with different concentrations of cocaine for 24 to 48 h
and then exposed to 1 or 3 µg of poly(I·C) per ml, respectively,
for 6 to 8 h. The resulting culture medium samples were analyzed
for IFN by bioassay. Cocaine caused an increase in the amount of IFN
induced by poly(I·C) in both L929 cells and M
in a dose-dependent
manner (Fig. 5). An enzyme-linked
immunosorbent assay for TNF-
indicated that cocaine produced a
dose-dependent decrease in TNF-
secretion from L929 cells and M
stimulated with poly(I·C) (data not shown).
|
incubated with 100 µg of cocaine per ml for 6, 12, 24, 48, or
72 h exhibited a time-dependent increase in the level of IFN
secretion, with maximal levels being obtained when cells were incubated
with cocaine for 48 h (Fig. 6). An
increase in IFN secretion over that of control-treated cells was not
observed until cells were incubated with cocaine for at least 24 h. An increase over time was not observed with L929 cells; however, a
significant increase in IFN was noted after only 12 h. This was
consistent with the pattern of antiviral activity observed after direct
exposure of cells to cocaine.
|
Cocaine augments IFN transcript levels.
To determine if the
increase in IFN secretion caused by cocaine was the result of an
increase in mRNA level, an RNase protection assay was performed on L929
cells and M
incubated with cocaine and stimulated with poly(I·C).
Densitometry was performed for results of multiple experiments, and the
average increase between control and cocaine-treated cells was
determined. In M
, an average of a two-fold increase over the control
was noted for IFN-
at the highest concentration of cocaine as
indicated by densitometry (Fig. 7A).
There was no expression of IFN-
and only a small amount of IFN-
transcript. In L929 cells, both IFN-
and IFN-
were up-regulated
(Fig. 7B). Densitometry indicated that 100 µg of cocaine per ml
increased IFN-
and IFN-
transcripts approximately four- and
three-fold over control values, respectively. No IFN-specific transcripts were detected in M
or L929 cells not stimulated with poly(I·C) (data not shown). Cocaine did not affect the production of
constitutively expressed mRNA of GAPDH or L32.
|
| |
DISCUSSION |
|---|
|
|
|---|
The studies presented here offer a more thorough characterization
of cocaine's antiviral effect. Cocaine produced a dose-dependent inhibition of plaque formation in L929 cells infected with either VSV
or MHV. This supports our previous finding showing cocaine's ability
to inhibit MHV replication in M
. It also demonstrates that
cocaine's antiviral effect is not exclusive to any one cell type or
virus and suggests that the effect is on a global antiviral product
found in common in the different cells used in this study.
In previous experiments with M
, it was determined that antiviral
activity could be transferred to fresh M
, indicating that cocaine-treated cells secreted antiviral products (9).
However, it was not determined what the identity of this secreted
product was or whether it accumulated over time, which would be
expected with the induction of secreted products. By incubating cells
with cocaine for a static amount of time and then adding fresh media without cocaine for different amounts of time, we were able to show
that the antiviral activity in the culture media did increase. This
indicated that cocaine probably induced active release of an antiviral
product into the media. It also suggests that cocaine is capable of
stimulating antiviral secretion without the presence of another inducer
[e.g., poly(I·C) or virus].
A possible explanation for the relatively small amount of antiviral activity detected in the transferred samples is that cocaine by itself is only a mild inducer of IFN secretion and cells do not constitutively produce IFN without a potent inducer. However, the stimulation by cocaine is multiplied by the presence of a potent IFN inducer like poly(I·C) or virus. Another possible explanation for the low antiviral activity in the transfer experiments is the necessity for removing cocaine during the latter stages of the experiment. Because the cells were cultured without cocaine stimulation for up to 48 h, the IFN induction would be expected to decrease. However, the removal of cocaine was necessary because L929 cells, which were being used to analyze antiviral products in transferred culture media, were also sensitive to cocaine's effects.
The addition of anti-IFN-
/
to either L929 cells or culture media
collected from cocaine-exposed L929 cells reversed the antiviral
activity of cocaine. These data are consistent with those obtained with
M
incubated with anti-IFN-
. The finding that anti-IFN-
did not
reverse the antiviral effect in L929 cells could be explained by the
fact that these cells secrete as much as 40% of their IFN as IFN-
(W. R. Fleischmann, Jr., University of Texas Medical Branch,
Galveston, personal communication). It is also important to note that
in these studies, murine M
produced primarily IFN-
, despite the
fact that the literature defines them as being primarily a source of
IFN-
. It was necessary to determine in a more quantitative manner
what effects cocaine had on IFN secretion. When cells were incubated
with different concentrations of cocaine and the IFN inducer
poly(I·C), a dose-dependent increase in IFN was observed. A
time-related increase was also seen in M
but not L929 cells. These
results are consistent with the antiviral response of M
and L929
cells exposed to cocaine and then challenged with virus, thus further
supporting the identity of this antiviral activity stimulated by
cocaine as being IFN. Because TNF-
has been shown to have antiviral
activity (23), experiments were performed to determine if
part of cocaine's inhibition of virus replication was due to an
increase in TNF-
secretion, possibly by acting in synergy with IFN.
However, the inhibition of TNF-
secretion by cocaine lends further
support for IFN being the primary antiviral mechanism of cocaine.
The increase in IFN observed in these studies is supported by a report
that acute cocaine exposure in vivo increased IFN-
secretion for
PBMC in cocaine-dependent human addicts (6). Also, Van Dyke
et al. reported that human NK cell activity and distribution were
increased after in vivo cocaine exposure (26). It has been
reported that a major effect of IFN is to increase NK cell activity
(2), thus leading to the possibility that the mechanism of
cocaine's effects on NK cells in that study was stimulation of IFN secretion.
An increase in secreted protein does not necessitate an increase in
protein production. Instead, alterations in secretion or stability of
the protein could affect the amount of product detected in the culture
media. Therefore, an analysis of the amount of mRNA for several IFN
genes was undertaken to determine if cocaine's effects on IFN were at
the transcriptional level. In an RNase protection assay, cocaine
produced dose-related increases in mRNA for both IFN-
and IFN-
,
with the greatest increase due to cocaine being observed in L929 cells.
These results suggest that cocaine affects IFN secretion by increasing
either the transcription of the IFN genes or the stability of the
resulting transcripts. The fact that not all of the inducible
transcripts detected in the assay were augmented supports
transcriptional regulation. This is consistent with the literature,
which states that the majority of IFN regulation occurs at the
transcriptional level (25). The
4 species of IFN-
was
chosen because it has previously been reported to be produced by L929
cells in larger amounts than the other IFN species (8).
Neither of the two housekeeping genes was affected by cocaine,
indicating that the increase in IFN mRNA levels was not due to an
overall increase in transcription. The fact that no IFN-specific
transcripts were detected in cells exposed to cocaine but not
poly(I·C) could be a result of mRNA levels being below the detection
limits of the assay. This is consistent with the fact that cells
produce high levels of IFN only in the presence of an inducer like
poly(I·C) or virus. This is further evidence that cocaine by itself
induces only a slight stimulatory effect on IFN production. Also in
support of this, previous research by other investigators, which has
been replicated in this lab, has found that cocaine, in the absence of
LPS or another stimulating agent, was insufficient to alter cytokine
secretion (13).
IFN has been demonstrated to inhibit cell proliferation. Di Francesco et al. have reported that cocaine inhibited rat fibroblast proliferation; however, no mechanism was described (4). We have also observed that when L929 cells were treated with cocaine for at least 24 h, there was a slight but significant reduction in cellular proliferation that was reversible by the addition of anti-IFN antibodies (unpublished observation). It is possible that cocaine up-regulates the expression of baseline IFN message, thus resulting in a mild inhibition of cell proliferation.
The concentrations of cocaine found in murine serum after a subchronic schedule of cocaine administration range from 1 to 3 µg/ml within 30 min of the last dose (12). However, cocaine is rapidly metabolized in the body, resulting in various end products that have been found to be pharmacologically active (11, 17, 21). The tissue deposition of these metabolites varies considerably, making a precise measurement of exposure to cocaine and its metabolites difficult. However, 3 µg of cocaine per ml inhibited virus replication in the present study, suggesting that this effect could be of biological significance. A recent study by members of this group has reported a 50% decrease in influenza virus present in the lungs of mice receiving subchronic cocaine exposure (7). This is further support for a biologically relevant effect of cocaine on virus replication.
Other investigators have reported that cocaine induced an enhancement
of viral replication. Peterson et al. reported that there was a
dose-dependent increase in HIV replication in PBMC as indicated by an
increased expression of the HIV p24 antigen (18). However,
the overall replication of virus was never assessed. The increase could
have been the result of enhanced protein secretion without a change in
infectious virus production. It should be emphasized that the cocaine
concentrations employed in the HIV studies were much lower (300 ng/ml)
than those used in the present study. Also, the considerable
differences between lymphocyte and M
responses could explain the
discrepancies in results. Our data demonstrate that cocaine enhances
IFN secretion in both murine peritoneal M
and L929 cells, but we
have not yet assessed this phenomenon in a human cell line.
This study has demonstrated that cocaine has the capacity to increase
the level of IFN secreted by murine thioglycolate-induced peritoneal
M
and L929 cells and that at least part of the regulation of IFN by
cocaine is on the level of transcript produced. These data correlate
with the decrease in overall virus replication that has been reported
in this and previous studies (9). The mechanism by which
cocaine enhances IFN production remains unclear. However, we have noted
an increase in intracellular calcium levels and mobilization in M
incubated with cocaine. As calcium has been shown to up-regulate gene
transcription (16), it is possible that there exists a
relationship between the augmentation of calcium and the increase in
IFN production by cocaine; however, further research in this area is necessary.
| |
FOOTNOTES |
|---|
* Corresponding author. Present address: Dept. of Microbiology and Immunology, Medical Research Building, Route 1070, University of Texas Medical Branch, Galveston, TX 77555-1070. Phone: (409) 772-4928. Fax: (409) 747-6869. E-mail: kjgratte{at}utmb.edu.
Present address: Department of Molecular Medicine, Institute of
Biotechnology at the University of Texas Health Sciences Center at San
Antonio, San Antonio, TX 78245.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bagasra, O., and R. J. Pomerantz. 1993. Human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells in the presence of cocaine. J. Infect. Dis. 168:1157-1164[Medline]. |
| 2. | Chebath, J., and M. Revel. 1992. The 2-5 A system: 2-5 A synthetases, isospecies and functions, p. 225-236. In S. Baron, D. H. Coppenhaver, F. Dianzani, W. R. Fleishmann, Jr., T. K. Hughes, Jr., G. R. Klimpel, D. W. Niesel, G. J. Stanton, and S. K. Tyring (ed.), Interferon: principles and medical applications. Department of Microbiology, The University of Texas Medical Branch at Galveston, Galveston. |
| 3. | Des Jarlais, D. C., and S. R. Friedman. 1988. HIV and intravenous drug use. AIDS 2(Suppl. 1):S65-S69. |
| 4. | Di Francesco, P., P. Francesca, C. Favalli, E. Tubaro, and E. Garaci. 1990. Inhibition of rat fibroblast cell proliferation at specific cell cycle stages by cocaine. Cell Biol. Int. Rep. 14:549-558[CrossRef][Medline]. |
| 5. | Di Francesco, P., F. Pica, C. Croce, C. Favalli, E. Tubaro, and E. Garaci. 1990. Effect of acute or daily cocaine administration on cellular immune response and virus infection in mice. Nat. Immun. Cell Growth Regul. 9:397-405[Medline]. |
| 6. | Gan, X., L. Zhang, T. Newton, S. L. Chang, W. Ling, V. Kermani, O. Berger, M. C. Graves, and M. Fiala. 1998. Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects. J. Interferon Res. 9:633-40. |
| 7. | Grattendick, K., D. L. Lefkowitz, and S. S. Lefkowitz. 2000. Inhibition of influenza virus replication by cocaine. Int. J. Immunopharmacol. 22:105-111[CrossRef][Medline]. |
| 8. | Lai, M., S. Boyer, and M. Beilharz. 1994. Molecular detection and identification of type I interferon mRNAs. Genet. Anal. Tech. Appl. 11:12-19[Medline]. |
| 9. | Lefkowitz, S. S., D. J. Brown, K. Grattendick, and D. L. Lefkowitz. 1997. Cocaine inhibits production of murine hepatitis virus by peritoneal macrophages in vitro. Proc. Soc. Exp. Biol. Med. 215:87-93[CrossRef][Medline]. |
| 10. | Lefkowitz, S. S., A. Vaz, and D. L. Lefkowitz. 1993. Cocaine reduces macrophage killing by inhibiting reactive nitrogen intermediates. Int. J. Immunopharmacol. 15:717-721[CrossRef][Medline]. |
| 11. | Ma, F., J. Zhang, and C. E. Lau. 1997. Determination of cocaine and its metabolites in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats. J. Chromatogr. B 693:307-312[CrossRef]. |
| 12. | Miller, S. R., L. D. Middaugh, W. O. Boggan, and K. S. Patrick. 1996. Cocaine concentrations in fetal C57BL/6 mouse brain relative to maternal brain and plasma. Neurotoxicol. Teratol. 18:645-649[CrossRef][Medline]. (Erratum, 19:75, 1997.) |
| 13. | Ou, D. W., M. L. Shen, and Y. D. Luo. 1989. Effects of cocaine on the immune system of Balb/C mice. Clin. Immunol. Immunopathol. 52:305-312[CrossRef][Medline]. |
| 14. | Pacifici, R., S. Di Carlo, A. Bacosi, and P. Zuccaro. 1993. Macrophage functions in drugs of abuse-treated mice. Int. J. Immunopharmacol. 15:711-716[CrossRef][Medline]. |
| 15. | Palamara, A. T., P. Di Francesco, M. R. Ciriolo, C. Bue, E. Lafavia, G. Rotilio, and E. Garaci. 1996. Cocaine increases Sendai virus replication in cultured epithelial cells: critical role of the intracellular redox status. Biochem. Biophys. Res. Commun. 228:579-585[CrossRef][Medline]. |
| 16. | Park, Y. C., C. D. Jun, H. S. Kang, H. D. Kim, H. M. Kim, and H. T. Chung. 1996. Role of intracellular calcium as a priming signal for the induction of nitric oxide synthesis in murine peritoneal macrophages. Immunology 87:296-302[CrossRef][Medline]. |
| 17. | Peterson, K. L., B. K. Logan, and G. D. Christian. 1995. Detection of cocaine and its polar transformation products and metabolites in human urine. Forensic Sci. Int. 73:183-196[CrossRef][Medline]. |
| 18. | Peterson, P. K., G. Gekker, C. C. Chao, R. Schut, T. W. Molitor, and H. H. Balfour, Jr. 1991. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. J. Immunol. 146:81-84[Abstract]. |
| 19. | Peterson, P. K., G. Gekker, C. C. Chao, R. Schut, J. Verhoef, C. K. Edelman, A. Erice, and H. H. Balfour, Jr. 1992. Cocaine amplifies HIV-1 replication in cytomegalovirus-stimulated peripheral blood mononuclear cell cocultures. J. Immunol. 149:676-680[Abstract]. |
| 20. | Peterson, P. K., G. Gekker, R. Schut, S. Hu, H. H. Balfour, Jr., and C. C. Chao. 1993. Enhancement of HIV-1 replication by opiates and cocaine: the cytokine connection. Adv. Exp. Med. Biol. 335:181-188[Medline]. |
| 21. | Phillips, D. L., I. R. Tebbett, and R. L. Bertholf. 1996. Comparison of HPLC and GC-MS for measurement of cocaine and metabolites in human urine. J. Anal. Toxicol. 20:305-308[Medline]. |
| 22. | Pyo, S., J. D. Gangemi, A. Ghaffar, and E. P. Mayer. 1991. Poly I:C-induced anti-herpes simplex virus type 1 activity in inflammatory macrophages is mediated by induction of interferon-beta. J. Leukoc. Biol. 50:479-487[Abstract]. |
| 23. |
Ruby, J.,
H. Bluethmann, and J. J. Peschon.
1997.
Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors.
J. Exp. Med.
186:1591-1596 |
| 24. | Shen, H. M., J. L. Kennedy, and D. W. Ou. 1994. Inhibition of cytokine release by cocaine. Int. J. Immunopharmacol. 16:295-300[CrossRef][Medline]. |
| 25. | Taniguchi, T. 1989. Regulation of interferon-beta gene: structure and function of cis elements and trans-acting factors. J. Interferon Res. 9:633-640[Medline]. |
| 26. | Van Dyke, C., A. Stesin, R. Jones, A. Chuntharapai, and W. Seaman. 1986. Cocaine increases natural killer cell activity. J. Clin. Investig. 77:1387-1390. |
| 27. | Vaz, A., S. S. Lefkowitz, A. Castro, and D. L. Lefkowitz. 1994. The effects of cocaine and its metabolites on the production of reactive oxygen and reactive nitrogen intermediates. Life Sci. 55:L439-L444. |
| 28. | Vaz, A., S. S. Lefkowitz, and D. L. Lefkowitz. 1993. Cocaine alters the respiratory burst and phagocytic activity of murine macrophages. Clin. Immunol. Immunopathol. 69:161-166[CrossRef][Medline]. |
| 29. | Vaz, A., S. S. Lefkowitz, and D. L. Lefkowitz. 1993. Effects of cocaine on the respiratory burst of murine macrophages. Adv. Exp. Med. Biol. 335:135-142[Medline]. |
| 30. |
Watzl, B., and R. R. Watson.
1990.
Immunomodulation by cocaine neuroendocrine mediated response.
Life Sci.
46:1319-1329[CrossRef][Medline].
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»